SARS CoV2 Studies in the Microbial Pathogenesis Section/LPD

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

Document text

Principal Investigator: Stephen  Leppla
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2021
Award: $20,392
Funding agency: National Institute of Allergy and Infectious Diseases

The monoclonal S9.6 antibody has the unique property of recognizing DNA/RNA hybrids in a sequence-independent manner. A polyclonal antibody having this specificity is the basis of hybrid capture ELISA-type commercial diagnostic assays for human papilloma virus (HPV) DNA in vaginal swabs. It follows that the S9.6 antibody offers a generic approach to detection and quantitation of any nucleic acid of known sequence. Development of this diagnostic platform could lead to methods for detection of any pathogen of interest. During FY2021 we have analyzed a variety of formats for use of S9.6 in detection of DNA of B. anthracis and Toxoplasma gondi, as models for future application to COVID RNA detection. In one successful format, poly-biotinylated single-stranded DNA probes complementary to B. anthracis mRNA were captured on an S9.6-coated assay plate and detected using enzyme-linked streptavidin. 

Optimization of S9.6 as a diagnostic tool would be aided by production of the antibody as a recombinant protein. This would facilitate its production as well as structure-function analysis and protein engineering. To achieve this, we used amino acid sequence data from several experimental approaches to deduce the S9.6 Fab sequence, had the heavy and light chain genes synthesized, and produced the Fab in expiCHO cells in amounts sufficient for structural analysis. Jinwei Zhang of NIDDK obtained a crystal structure of the S9.6 Fab in complex with a small DNA/RNA hybrid. The structure helps to explain how the antibody discriminates against RNA:RNA duplexes to achieve specificity for DNA/RNA duplexes. 

Optimal sensitivity of hybrid capture type assays with S9.6 requires high quality reporter enzyme conjugates. One of our S9.6 Fab constructs is equipped with a C-terminal amino acid sequence that is the substrate for sortase-mediated conjugation to proteins having a tri-glycine N-terminal signal. After producing secreted embryonic alkaline phosphatase (SEAP) with the required tri-glycine sequence (again using the expiCHO cells), these two proteins were conjugated by sortase in excellent yield to produce a purified and fully defined S9.6 Fab-SEAP conjugate. This was shown in several assay formats to be effective in detecting DNA/RNA hybrids.  Subsequently, we also produced in the expiCHO cells a genetic fusion of the S9.6 Fab to SEAP and confirmed its activity.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Ab response><Alkaline Phosphatase><Amino Acid Sequence><Antibodies><Antibody Formation><Antibody Production><Area><Assay><B anthracis><B. anthracis><Bacillus anthracis><Bioassay><Biologic Assays><Biological Assay><C-terminal><COVID><COVID-19 virus><COVID19 virus><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Clinical Treatment Moab><CoV disease><CoV-2><CoV2><Complex><Coronaviridae><Coronavirus><Crystallization><DNA><DNA Hybridization Probes><DNA Probes><Data><Deoxyribonucleic Acid><Detection><Development><Diagnostic><Diagnostic Method><Diagnostic Procedure><Diagnostic Reagent Kits><Diagnostic Technique><Dot Immunoblotting><ELISA><Embryo><Embryonic><Enzyme Gene><Enzyme-Linked Immunosorbent Assay><Enzymes><Future><GGG peptide><Genes><Genetic><Gly-Gly-Gly><HPV><Human Papilloma Virus><Human Papillomavirus><Hybrids><Infectious Human Wart Virus><Intracellular Communication and Signaling><Lateral><Lead><Light><Link><MAb Therapeutics><Mediating><Messenger RNA><Modeling><Modification><Monoclonal Antibodies><N-terminal><NH2-terminal><NIDDK><National Institute of Diabetes and Digestive and Kidney Diseases><Non-Polyadenylated RNA><Nucleic Acids><Pathogenesis><Pb element><Photoradiation><Preparation><Primary Protein Structure><Production><Property><Protein Engineering><Proteins><RNA><RNA Gene Products><Reagent><Recombinant Proteins><Recombinants><Reporter><Research Resources><Resources><Ribonucleic Acid><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Signal Transduction><Signal Transduction Systems><Signaling><Single-Stranded DNA><Specificity><Strepavidin><Streptavidin><Stress><Structure><Swab><System><Testing><Therapeutic Agents><Therapeutic Monoclonal Antibodies><Toxoplasma><Vagina><Vaginal><Viral><Work><Wuhan coronavirus><alkaline phosphomonoesterase><anthracis><antibody biosynthesis><biological signal transduction><corona virus><corona virus disease><coronavirus disease><coronavirus disease 2019 virus><cost><detection method><detection procedure><detection technique><developmental><diagnostic assay><diagnostic kit><diagnostic platform><diagnostic system><dot blotting><genetic protein engineering><glycerophosphatase><glycyl-glycyl-glycine><hCoV19><heavy metal Pb><heavy metal lead><immunoglobulin biosynthesis><improved><interest><mAbs><mRNA><microbial><monoclonal antibody drugs><nCoV2><pandemic><pandemic disease><pathogen><point-of-care diagnostics><polyclonal antibody><protein design><protein sequence><severe acute respiratory syndrome-CoV><sortase><srtA gene product><success><test kit><therapeutic mAbs><tool><triglycine><viral DNA><viral RNA><viral detection><virus DNA><virus RNA><virus detection><wart virus>